Related Experiment Video
Updated: Jun 2, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Insulin resistance and protein catabolism in critically ill patients]
Jeffrey Bierbrauer1, Steffen Weber-Carstens
1Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charité Mitte, der Charité-Universitätsmedizin Berlin, Germany. Jeff rey.Bierbrauer@charite.de
Abstract:
Hyperglycemia is a frequently observed phenomenon in critically ill patients, affecting numerous patients without a history of impaired glucose tolerance or diabetes. During critical illness, hyperglycemia may result from decreased peripheral glucose uptake and/or utilisation in presence of normal or elevated plasma insulin levels (peripheral insulin resistance) as well as an increase in hepatic glucose production due to augmented glycogenolysis and gluconeogenesis resulting from stress and/or central (hepatic) insulin resistance. As there are a number of factors that cause or aggravate hyperglycemia / insulin resistance during the intensive care unit (ICU) stay, a multifactorial etiology is likely. Furthermore, animal models of sepsis suggest a decrease in anabolic insulin signalling within skeletal muscle.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Type II Diabetes II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome I : Introduction
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
